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(57) ABSTRACT 
A stent device for treating an aneurysm is disclosed. The stent 
device comprises an expandable balloon with a channel 
extending through said balloon from one side to another, and 
a supporting stent connected to said balloon. In an operative 
disposition, when the expandable balloon is expanded, the 
Supporting stentis arranged at least partly within said channel 
of said expandable balloon. Further, the Supporting stent has 
walls which are permeable to blood. The stent device may be 
introduced and removed by endoscopic procedures, with a 
relatively simple procedure. Thus, the stent device is highly 
useable for fast and temporary treatment of ruptured aneu 
rysms. 
15 Claims, 12 Drawing Sheets 
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1. 
DEVICE AND METHOD FORTREATING 
RUPTURED ANEURYSMS 
FIELD OF THE INVENTION 
The present invention relates to a stent device and a kit for 
treating aneurysms. 
BACKGROUND OF THE INVENTION 
Arteries can have a pathological dilatation called aneu 
rysms. The most common location for an aneurysm is in the 
aorta just below the take off of the renal arteries. It occurs in 
approximately 5% of the population above the age of 60 
years. About 75% of the aortic aneurysms are asymptomatic 
and are found unexpectedly. An aortic aneurysm can rupture, 
which is a life-threatening condition because of extensive 
blood loss into the abdominal cavity. The risk for rupture 
increases with size. The rupture is most commonly located at 
the lower left part of the aneurysm. Approximately 80% of the 
patients facing a rupture die immediately. Those who reach a 
hospital have a chance of Survival averaging 45%. 
The optimal initial treatment for a patient with a ruptured 
aortic aneurysm would theoretically be to first substitute for 
the losses of blood and other essential body fluids and opti 
mize basic functions such as the cardiopulmonary and renal 
capacities. The risk for re-bleeding and immediate death is 
unfortunately so big that there is no time to finalize Such 
undertakings. There are two different interventions available 
today. One in which the abdominal cavity is opened and the 
ruptured part of the aorta is replaced with an artificial graft. 
This is a major operation and the traditional method. 
An alternative treatment is to exclude the aneurysm with an 
endovascular procedure. An artificial graft is placed within 
the aneurysmal sac which excludes the aneurysm from the 
blood flow and pressure and thereby stop further blood loss. 
The graft is inserted through the femoral arteries in the groins. 
This intervention is less traumatic but needs X-ray investiga 
tions to measure the optimal dimensions of various parts of 
the graft to be implanted since that vary considerably between 
individuals. These investigations take time. Furthermore, the 
proximal control above the bleeding point is achieved 
through a balloon, which is applied adjacent to the renal 
arteries. This blockage will influence the renal circulation and 
eventually also the circulation to visceral organs with poten 
tial serious consequences to follow. 
Known prostheses for use in Such interventions are e.g. 
disclosed in US2005033416, US 2007 156228, US 
2007282423, WO 2004/004603, US 2004/0193245, WO 
97/19653 and WO 98/41167. 
Both the above-discussed types of interventions can only 
be performed in hospitals of considerable size with extensive 
services. 
Consequently, the current methods of treating aneurysms 
have disadvantages including too little time to execute an 
optimal treatment, which often leads to fatal consequences 
for the patient. For example optimally, there is a need for time 
of transport of severely sick patients to Suitable hospitals, 
time to Substitute and optimize patients before any type of 
intervention and time for necessary X-ray interventions and 
measurements to find a Suitable endovascular graft. 
Furthermore the traditional practice does not follow the 
proven principles for improved Survival in connection to Sud 
denbig physical and physiological traumas. These principles 
can be described in the following two steps: i) damage control 
with minimal interventions and ii) delayed final repair. 
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There is therefore a need for a device and method that 
enables a faster and less traumatic procedure to take care of 
the immediate life-threatening condition. 
SUMMARY OF THE INVENTION 
It is therefore an object of the present invention to provide 
a device, kit and method enabling a procedure which allevi 
ates the above-discussed problems of the prior art. 
This object is achieved with a device, kit and a method 
according to the appended claims. 
According to a first aspect of the present invention there is 
provided a stent device for treating an aneurysm comprising: 
an expandable balloon with a channel extending through said 
balloon from one side to another; and a Supporting stent 
connected to said balloon, and in an operative disposition, 
when the expandable balloon is expanded, arranged at least 
partly within said channel of said expandable balloon, 
wherein said supporting stent has walls which are permeable 
to blood. In the operative disposition, the Supporting stent is 
preferably arranged to extend over essentially the whole 
channel of the expandable balloon, and also preferably 
arranged to extend outside said channel. 
This stent device is relatively straightforward to introduce 
into an aneurysm, making the medical procedure fast. Fur 
ther, the stent device is useable for essentially all patients and 
on aneurysms of any size and location. Consequently, pre 
procedural measurements and adaptations are not necessary. 
Thus, the new stent device may be used to quickly obtain a 
reliable coverage of the site of rupture of the aneurysm by 
means of the expandable balloon. At the same time, the chan 
nel in combination with the supporting stent provides a fluid 
communication through the aneurysmal area, thereby allow 
ing for sufficient blood flow distal to the location of the 
aneurysm. Hereby, the stent device can be used to alleviate the 
acute condition of the patient, and remain in place for a 
Sufficient time to prepare for a more complicated medical 
procedure. Such as arrangement of an artificial replacement 
graft with an endovascular intervention oran open operation. 
Thus, time is hereby provided to allow e.g. transport to an 
adequate hospital for a more complicated Subsequent proce 
dure, measurement and planning in preparation for a Subse 
quent procedure, and time to prepare and stabilize the patient 
for the Subsequent intervention. 
Thus, the present invention is consistent with the above 
discussed principles of treatment of Sudden serious physical 
and physiological traumas described in the two steps: damage 
control with minimal intervention and delayed final repair. 
Thus, the new stent device provides means for quickly 
achieving a temporary Solution which provides ample time to 
adequately prepare for a more permanent solution. The stent 
device can remain in place during a time period ranging from 
a few hours to some days, or even a week or more, depending 
on e.g. the state of the patient. It is envisaged that the new stent 
device will normally be used for about 24–48 hours. 
With the new stent device, the expandable balloon can be 
inflated to temporarily cover the rupture of e.g. an aortic 
aneurysm. The stent device has a channel, preferably cen 
trally arranged within the balloon, with a permeable Support 
ing stent, such as a spiral-stent, which will secure the blood 
flow to distal branches. The stent device is very compact 
during delivery, and by e.g. positioning the balloon and the 
Supporting stent in line in a delivery-sheath the diameter of 
the device will be reduced during insertion. Hereby, the stent 
device is insertable through a relatively limited opening. 
The stent device can e.g. be inserted through the femoral 
arteries in the groins as an endovascular procedure. When the 
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3 
stent device has reached its preferred destination in the aneu 
rysm, the balloon is expanded to the size needed. Since the 
device is not dependent on the configuration or size of the 
aneurysm, the principle “one size fits all can be applied, 
which excludes the need for measurements before insertion. 
Due to the flexibility and configuration of the expandable 
balloon, the process can in a preferable embodiment be 
reversed by e.g. deflating the balloon in a controlled manner 
while unisonly pulling the central scaffolding in order to 
retrive the provisional device to be replaced by a permanent 
Solution. 
Thus, the stent device is easy and quick to apply and to 
remove, and it fits anyone. The device can be used at any 
hospital and will give the necessary time for transportation, 
time for medically optimizing the patient and time for X-ray 
investigations. Furthermore, it will follow the known prin 
ciples for better survival in connection to life-threatening 
situations; damage control with a minimal intervention and 
delayed final repair. Thus, the present device may decrease 
the risk for severe or fatal consequences for patients with 
ruptured aneurysms. At the final position the balloon will 
protect from further bleeding by coverage of the rupture site. 
This position will be maintained in an adequate position and 
the maintaining may be further Supported e.g. by having an 
upper surface profile of the balloon which presses the balloon 
distally and laterally. The distal mechanical movement will be 
further enhanced by having a stent with a smaller diameter 
than the diameter of the adjacent non-aneurysmal aorta. This 
will act as a pressure-reducer with a higher blood pressure 
above than below the device, forcing it downwards. 
Preferably, the relative position between the expandable 
balloon and the supporting stent in an axial direction of the 
stent device is variable, and wherein in an insertion disposi 
tion, the expandable balloon and the Supporting stent are 
arranged in line with each other. However, it is also possible 
to arrange the balloon, in the insertion disposition, within the 
Supporting stent, or alternatively outside the Supporting stent. 
In particular, this latter alternative would be feasible when the 
Supporting stent has a variable diameter, since it would then 
still be possible to obtain a compact and thin device for 
insertion. 
The diameter of the stent device, in a collapsed disposition, 
is preferably significantly Smaller than the original size of the 
blood vessel in which the aneurysm has occurred, and also 
significantly smaller than the size of the blood vessel in which 
the stent device is to be introduced and removed during the 
endovascular insertion and extraction procedures. 
Further, the balloon is preferably connected to the support 
ing stent only at or adjacent to a proximal end of said Sup 
porting stent. Hereby, the expandable balloon may in an inser 
tion disposition be arranged within or in line with the 
Supporting stent, and being eversible into an expanded State 
outside said Supporting stent in the operative disposition. 
However, other ways of making the balloon and the Support 
ing stent displaceable in relation to each other are also fea 
sible. Preferably, the balloon is also made of a relatively thin 
expandable material. 
In one embodiment, the connection of the Supporting stent 
to the balloon is only at the top of the stent. This is equal to that 
the upper luminal entrance of the stent, will function as a 
pressure reducing part. With the balloon inflated this provides 
a preferably central channel with a bigger diameter than the 
stent below its upper luminal entrance. The balloon will have 
a tendency to move and expand laterally—away from the 
stent. Since the stent is permeable, blood flow distally will not 
have a risk for severe mechanical obstruction through the 
device in its aortic position. The blood flow to the legs is 
10 
15 
25 
30 
35 
40 
45 
50 
55 
60 
65 
4 
further secured by the extension of the stent into one of the 
iliac arteries. The distal outflow through the device will 
thereby be optimally positioned in connection to the aortic 
bifurcation. 
Further, the connection or integration of the stent in the 
upper surface of the balloon will support the shape of the 
Surface of the balloon. This Surface may, as discussed above, 
enhance the movement of the balloon downwards and later 
ally towards the rupture site. At removal this connection/ 
integration will after the deflation of the balloon facilitate the 
docking of the balloon into an extraction sheath, e.g. by 
pulling at distal threads connected to the stent device. The 
stent and the balloon may hereby be docked in line, with the 
balloon on the top. The principal steps to have a device firmly 
packed, expanded in a working position and shrinked to make 
it removable through an endovascular approach is thereby 
achieved. 
Hereby, it becomes possible to arrange the balloon and the 
stent in a very compact state, with a very narrow diameter, for 
insertion, which makes the insertion easy. 
Further, the expandable balloon preferably has a torus 
shape in an expanded State. This will Support its function to 
cover the site of rupture. The lower end of the channel through 
the balloon should preferably be concave, or funnel-shaped, 
to secure the blood flow to the arteries below. Additionally or 
alternatively, the upper end may also be concave, further 
improving the flow conditions and the fixation of the balloon. 
Such a surface will together with the blood flow, force the 
balloon downwards and outwards. 
The balloon preferably comprises parts with a wall mate 
rial of different thickness and/or flexibility, arranged to pro 
vide the desired shape when inflated. For example, the walls 
of the balloon may have a constitution that provides a balloon 
with a tendency to first expand outwards during inflation, and 
which provides a concave, funnel-like appearance of the end 
portions close to the channel. 
The Supporting stent preferably has a variable diameter, 
said diameter being remotely controllable, making it possible 
to reduce the diameter from a distance. The Supporting stent 
is also preferably self expandable, whereby it automatically 
strives to resume an expanded State after being released from 
a compressed State. Hereby, the Supporting stent will e.g. 
automatically become larger when released from a com 
pressed state within the delivery sheath. 
Further, the supporting stent can preferably be formed of 
threads arranged in at least two interfoliated spirals. The term 
“threads” is in this application to be construed broadly, to 
cover any thread-like structure, such as thin bands, filaments, 
twinned wires and the like in many different possible mate 
rials such as various metals or plastics. In this case, the ends 
of the threads forming the spirals preferably extend beyond 
the Supporting stent, whereby variation in the tension of these 
extending thread ends provides the remote controllability of 
the diameter of the Supporting stent. Hereby, these threads can 
be positioned through the vascular access and on the patients 
external surface. When the device needs to be explanted, 
pulling of the threads will reduce the diameter of the spiral 
stent making also the removal easy. However, other ways of 
obtaining a controllably variable diameter are also feasible. 
Further, it is also possible to use a Supporting stent with a fixed 
diameter. 
Thread ends of the threads forming the stent will preferably 
extend beyond the tube-like form of the stent, and out through 
the entry site of the arterial system of the patient, positioned 
on the skin of the patient. Hereby, the thread ends may be 
pulled for control of the diameter of stent. Furthermore, the 
thread ends make it possible at removal to apply a docking 
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sheath around these threads already outside the vascular tree. 
The sheath can be advanced to a position where the stent has 
its form of a tube and when pulling at the external thread ends 
the tube will reduce its diameter and the docking sheath can 
slide in the space between the inflated balloon and the stent in 
the aorta until it reaches the upper connection between the 
stent and the balloon. 
The permeable Supporting stent, such as the above-dis 
cussed spiral-stent, will secure the blood flow to subsequent 
(downstream) arteries, such as the arteries to both legs of the 
patient. The spiral-stent will expand to a predetermined size 
when the stent device has been inserted into the aneurysm. 
However, it is also possible to use a Supporting stent with a 
fixed diameter. 
The Supporting stent (or several Supporting stents) will 
preferably extend into one of the outflow arteries to secure the 
position of the stent device in relation to these arteries. The 
Supporting stentis preferably only connected to the balloon at 
its top, where it can be intergraded to the upper surface of the 
balloon to support the shape of this surface and to facilitate 
removal of the balloon. The lack of connection between the 
Supporting stent and the balloon along the main body of the 
supporting stent facilitates flow of blood to the other arteries, 
in which it does not extend. The lack of connection between 
the Supporting stent and the balloon along the main body of 
the Supporting stent is also advantageous to get a sheath in 
place for removal. 
The spirals in the Supporting stent when made of spirals are 
preferably positioned opposite each other at all locations in 
their tubular formation. The threads forming the spirals pref 
erably extend beyond the tubular part into a standard straight 
configuration. Pulling these straight threads will make the 
spiral-stent longer and simultaneously reduce its diameter 
thereby increases also the space between the inflated balloon 
and the spiral-stent. Both motions are advantageous when 
removing the stent device with e.g. a sheath. The anti-force to 
the pulling of the threads can e.g. be provided by the inflated 
balloon, or by an anchored guide wire. 
The diameter of the Supporting stent in the operative dis 
position is preferably smaller than the original diameter of the 
blood vessel in which the aneurysm has occurred. Thus, the 
diameter of the Supporting stent is preferably smaller than a 
normal aorta (i.e. less than 2 cm). Through the reduction in 
diameter the blood pressure will be higher above the channel 
than below it. This will force the whole stent device down 
wards, to secure its position where most ruptures occur and 
improve perfusion of proximal organs necessary for a persis 
tent life. The small diameter will also be advantageous for 
providing a thin device during insertion. 
The distal mechanical movement of the stent device will 
also be further enhanced by having a stent with a smaller 
diameter than the blood vessel (typically the aorta) where it is 
placed. This will act as a pressure-reducer with a higher blood 
pressure above than below the device forcing it downwards. 
Another advantage with the difference in diameters between 
the aorta and the device is that the reduced circulating blood 
volume will mainly be distributed above the renal arteries— 
to organs necessary to keep the patientalive in his threatening 
condition. These organs are the viscera in the abdominal 
cavity, the kidneys, the heart and the brain. The priority will 
be given in front of circulation to the legs. However the 
circulation to the legs will still be more than sufficient as long 
as the patient is lying in a bed. 
Further, the expandable balloon preferably has a length in 
the axial direction of the stent device which is shorter, and 
preferably significantly shorter, than the length of the aneu 
rysm. In particular, it is preferred that the length of the balloon 
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is dimensioned not to threaten the flow to the renal arteries 
when arranged in the active position, and also not so long that 
it makes the device unsuitable for aneurysms with longer 
necks. Hereby, the balloon covers the main distance between 
the renal arteries to the aortic bifurcation. 
According to another aspect of the present invention there 
is provided a kit for treating an aneurysm comprising: a 
delivery sheath; and a stent device of the type discussed in the 
foregoing; wherein the delivery sheath releasably accommo 
dates the stent device. The stent device will be released from 
the delivery sheath at its working position. 
Hereby, similar advantages as discussed above in relation 
to the first aspect of the invention are obtained. 
Preferably, the balloon is connected to the supporting stent 
at one end and to the delivery sheath at an opposite end. 
Further, the connection between the balloon and the delivery 
sheath is preferably releasable. 
Thus, the balloon and the Supporting stent may initially be 
positioned in line in the delivery-sheath to reduce the diam 
eter of the device during insertion. This will provide a very 
narrow diameter, and make the insertion much easier. The 
balloon will e.g. be present at the upper end of the delivery 
sheath and the supporting stent below. The balloon will 
hereby preferably be connected to the top of the delivery 
sheath so it can be everted over the supporting stent when the 
delivery sheath is pulled backwards. The top of the delivery 
sheath preferably has markers possible to see under e.g. fluo 
roscopic vision. A pusher may also be present at the lower end 
of the Supporting stent in the delivery sheath to be used as an 
anti-force when the delivery sheath is pulled back. A channel 
for inflation of the balloon and the straight extension of the 
metal threads connected to the supporting stent may extend 
through the end of the delivery sheath. 
The connection between the delivery sheath and the stent 
device, and in particular between the delivery sheath and the 
balloon, is preferably releasable, which makes it possible to 
separate the delivery sheath after insertion. One possible 
alternative is that the connection is strong against pulling 
forces but weak against torsion, which makes it possible to 
release the delivery sheath by means of twisting. Another 
alternative to releasing the connection between the delivery 
sheath and the balloon is e.g. to have parts held together with 
a thread that can be pulled away to break the connection. 
Further, at least one, and preferably both, the stent device 
and the delivery sheath may comprise markers visible by 
external observation, such as by means of fluoroscopic vision. 
Preferably, such marks are arranged at the top and bottom of 
the Supporting stent, to ensure perfect position. Additionally 
or alternatively, there can be provided a marker between the 
top and the bottom. This middle marker will preferably be 
located at a distance from the top of the spiral-stent, which is 
equal to the length of the balloon. The latter example of 
middle marker is particularly useful when the stent has a 
length making it suitable to be extended into one of the 
arteries to the leg. 
The kit preferably also comprises an extraction sheath for 
removal of the stent device. The extraction sheath is prefer 
ably arranged to be inserted into the aneurysm, and to admit 
for the stent device to be collapsed therein. For example, the 
Supporting stent may be self-expandable and is in one setting 
formed with threads in a spiral-antispiral formation. The 
thread ends may in one configuration extend beyond the 
tubular formation of the Supporting stent. By pulling in these 
extended thread ends the diameter of the supporting stent will 
be reduced, making it possible to remove the stent device 
from the aneurysm. Thereafter, it may e.g. be replaced by a 
permanent solution by an endovascular procedure. The 
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removal will in one embodiment include the docking of the 
stent and connected balloon in a removal sheath similar to the 
delivery sheath. 
According to still another aspect of the present invention, 
there is provided a method for treating an aneurysm, com 
prising the steps of inserting a kit of the above-discussed type 
into the aneurysm; pulling back the delivery sheath, thereby 
releasing the stent device; and expanding the expandable 
balloon in the aneurysm, wherein a fluid communication 
through the aneurysm is created through the channel in the 
balloon. 
Hereby, similar advantages as discussed in the foregoing in 
relation to the other aspects of the invention are obtained. 
These and other aspects of the invention will be apparent 
from and elucidated with reference to the embodiments 
described hereinafter. 
BRIEF DESCRIPTION OF THE DRAWINGS 
For exemplifying purposes, the invention will be described 
in closer detail in the following with reference to embodi 
ments thereof illustrated in the attached drawings, wherein: 
FIG. 1 is a schematic overview of a kit including a stent 
device according to one embodiment of the present invention, 
in a compact insertion disposition; 
FIG.1a is an exploded tip view of the stent as illustrated in 
FIG. 1: 
FIGS. 2-7 illustrate different steps when inserting the stent 
device of FIG. 1 into an operative disposition: 
FIG. 8 illustrate the stent device of FIG. 1 in an operative 
disposition; and 
FIGS. 9-11 illustrate different steps when removing the 
Stent device of FIG. 1. 
DESCRIPTION OF PREFERRED 
EMBODIMENTS 
In the following detailed description, preferred embodi 
ments of the present invention will be described. However, it 
is to be understood that features of the different embodiments 
are exchangeable between the embodiments and may becom 
bined in different ways, unless anything else is specifically 
indicated. It may also be noted that, for the sake of clarity, the 
dimensions of certain components illustrated in the drawings 
may differ from the corresponding dimensions in real-life 
implementations of the invention. Even though in the follow 
ing description, numerous specific details are set forth to 
provide a more thorough understanding of the present inven 
tion, it will be apparent to one skilled in the art that the present 
invention may be practiced without these specific details. In 
other instances, well known constructions or functions are not 
described in detail, so as not to obscure the present invention. 
With reference to FIG. 1, a kit according to an embodiment 
of the invention includes a stent device as schematically illus 
trated. The kit comprises a delivery sheath 1, which accom 
modates a balloon 2 in a compact state, arranged at the proxi 
mal end of the delivery sheath, and formed into a rounded tip 
portion. Below the balloon 2, and connected to the balloon, is 
a Supporting stent 3. Further, a pushing rod or insertion shaft 
4 is arranged displaceable inside the delivery sheat. The push 
ing rod 4 will be present at the lower, distal end of the Sup 
porting stent 3 in the delivery sheath 1 to be used as an 
anti-force when the delivery sheath is pulled back. 
The delivery sheath 1 is preferably made of plastic mate 
rial. The arrangement of the balloon and the Supporting stent 
in line in the delivery-sheath provides a very small diameter 
of the device during insertion. The balloon is preferably con 
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nected to the top of the delivery sheath, by means of a con 
nection 13 (see also FIG. 4), so it can be everted over the 
supporting stent (see below) when the delivery sheath is 
pulled backwards (see also FIG. 4-6). The top of the delivery 
sheath preferably has markers 12 possible to see under fluo 
roscopic vision. 
Asbest seen in e.g. FIG. 7, the balloon comprises a channel 
21 extending through said balloon from one side 22 to another 
side 23. Preferably, the channel is arranged centrally in the 
balloon. Further, a thin tubing 24 forming a channel for infla 
tion of the balloon is preferably extended to the end of the 
delivery sheath. 
The balloon is preferably torus-shaped and thin enough to 
be well packed. The balloon is preferably connected to the top 
of the delivery sheath. The connection site of the balloon to 
the delivery sheath will later be at the lower end of the stent 
device after evertion (see below). The connection between the 
balloon and the delivery sheath is preferably possible to 
release. One possible alternative is that the connection is 
strong against pulling forces but weak against torsion. 
Another alternative is to pull away a thread, which initially 
keeps the parts together inducing the release. 
The Supporting stent 3 is connected to the balloon, and is, 
in an operative disposition, when the expandable balloon and 
the Stent are expanded, arranged at least partly within the 
channel 21 of the balloon. Further, the supporting stent has 
walls which are permeable to blood. 
The supporting stent 3 is preferably formed of two or more 
spirals 31, curled interfoliated in different direction. The spi 
rals 31 in the spiral-stent are preferably positioned opposite 
each other at all locations in their tubular formation. The 
supporting stent will expand to a predetermined size when the 
delivery sheath is pulled back. The spirals are preferably 
made of metal threads, and also, the threads forming the 
spiral-stent preferably extends beyond the tubular part into 
control ends 32 of a standard straight configuration. These 
control ends 32 can be positioned through the artery and on 
the patient’s external surface. The threads forming the spirals 
are extended beyond the tubular part into a standard straight 
configuration. Pulling of these straight threads will make the 
spiral-stent longer and simultaneously reduce its diameter 
thereby increases also the space between the inflated balloon 
and the spiral-stent. Both motions are advantageous for 
removing the stent device with a sheath. The anti-force to the 
pulling of the threads can be executed by the inflated balloon. 
The threads at the upper end of the stent can also preferably be 
extended and integrated with the balloon (see also FIG. 7). 
Marker(s) 12 may be provided on the delivery sheath, 
visible e.g. fluoroscopic control to ensure perfect position. 
Further, there may be marker(s) 33 at the top and bottom of 
the tubular part of the supporting stent that are visible with 
e.g. fluoroscopic control to ensure perfect position. There 
may also be marker(s)34 between the markers at the top and 
bottom of the tubular part of the stent. These middle markers 
can e.g. be located at a distance from the top of the spiral 
stent, which is equal to the length of the balloon. The size of 
the spiral-stent is preferably of a diameter sized so that the 
blood pressure will be significantly higher above the device 
than below it. This fact in itself implies priority of the blood 
Support to the upper organs in the body. This is obtained by 
having a diameter of the expanded stent being Smaller than 
the diameter of the artery where it is placed. 
The Supporting stent is preferably only connected to the 
balloon at its top, where it can be intergraded to the upper 
surface of the balloon to facilitate removal (FIG. 7). 
An example of how the kit and stent device can be used will 
now be discussed in more detail, with reference to FIGS. 2-7. 
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In this example, the stent device is arranged to temporarily 
cover the rupture of the aorta, whereby the central channel 
with the supporting stent ensures blood flow to both legs. 
However, it is to be acknowledged by someone skilled in the 
art that the stent device and kit of the present invention may 
also be used in a similar manner for treating other types of 
aneurysms. 
In a first step, a puncture is made into a femoral artery (FIG. 
2), and a guide wire is inserted into the artery, and through the 
aneurysm. Typically, the main side (usually the right side) is 
used for introducing the guide wire, for positioning it in the 
thoracic aorta. This procedure is perse known in the art. 
The kit as discussed in the foregoing is then inserted, fol 
lowing the guide wire, through the femoral artery in the groins 
as an endovascular procedure (FIG. 3), and up to the intended 
position in the aneurysm in the aorta (FIG. 4). The position is 
controlled by the marks at the top and bottom of the spiral 
stent and by the marks at the top of the delivery sheath. The 
lower end should preferably be in the iliac artery. 
In this position, the delivery sheath is pulled downwards 
(FIG. 5). This force is counteracted by the pushing rod 4. 
The position is preferably secured when the balloon has 
left the delivery sheath which is when the upper end of the 
spiral-stent is at the tip of the delivery sheath. This can be 
identified when the markers at the top of the delivery sheath 
and the top of the spiral-stent are at the same level. The upper 
and the middle markers on the spiral-stent are hereby in the 
aorta. The balloon is fully everted when the tip of the delivery 
sheath is at the level of the middle marker on the spiral-stent. 
The everted balloon is now inflated. The balloon should 
preferably first be partly inflated, and preferably with a solu 
tion which can be identified under fluoroscopic vision. Then, 
the balloon may, if necessary be pulled downwards so the 
balloon touches the bottom of the aneurysm. This might be 
achieved automatically by the blood pressure on the top of the 
balloon. The balloon is then fully inflated (FIG. 7) so that it 
essentially fills the aneurysm. Inflation of the balloon is made 
under control of the inflation pressure, until it touches the 
side-walls of the aorta. 
Subsequently, the delivery sheath is disconnected from the 
balloon. If the connection between the delivery sheath and the 
balloon is based on different strengths between pulling and 
twisting forces, the delivery sheath should hereby be twisted 
to release the balloon from its connection to the delivery 
sheath. Then, the delivery sheath may be pulled out. 
The stent device is now in an operative position (FIG. 8). 
Externally the stent device is still controllable by means of the 
thin tubing to inflate the balloon and the control ends of the 
spiral-stent. The Supporting stent may extend into one of the 
iliac arteries to secure the position of the stent device in 
relation to the arteries to the legs. The result may be con 
stantly verified with fluoroscopy and with radio-opaque dye 
from the left side. In this disposition, the aneurysm is tempo 
rarily treated, and sufficient blood flow is obtained through 
the stent device. 
When it is decided to be clinically appropriate to remove 
the stent device, both femoral arteries in the groins may be 
punctured. The externally placed threads of the stent can be 
placed within the lumen of the punctating needle. Thereafter, 
a guide wire may again be arranged through the aneurysm 
(FIG. 9), and an extraction or docking sheath 5 may be intro 
duced from the right side and be positioned in the lower part 
of the iliac arteries, below the spiral-stent. The docking sheath 
preferably has marks at its tip that can be identified. 
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The external control ends, i.e. the extension from the spi 
ral-stent, may then be pulled. The force will be counteracted 
by the balloon. Hereby, the spiral-stent gets a big reduction in 
diameter. 
The docking sheath 5 is then inserted over the whole spiral 
stent (FIG. 10). This may be identified when the tip of the 
docking sheath is at the same level as the top of the spiral 
stent. The balloon may then be deflated. 
Further pulling of the control ends will then pull the upper 
surface of the balloon into the docking sheath (FIG. 11). 
When the balloon is completely pulled into the docking 
sheath, the docking sheath may be removed with the stent 
device inside. 
In the case of a ruptured aortic aneurysm both femoral 
arteries in the groins may be punctured. The opposite side to 
the one where the stent device is inserted can then be a 
back-up in case of a Sudden drop of blood pressure. In such a 
situation proximal control can be reached with an occluding 
balloon from that alternative side (usually the left side). 
The inflation of the expandable balloon may also be con 
trolled in accordance with the pressure in the balloon. For 
example, the tubing used to inflate/deflate the expandable 
balloon may be connected to a pressure gauge. Hereby, the 
pressure may be monitored, for control of the inflation pro 
cess during insertion of the stent device. Additionally or alter 
natively, the pressure sensor may also be used to continuously 
control the expansion of the balloon when it is in the operative 
position, as well as during deflation for removal of the stent 
device. Specifically, the inflation may be controlled indepen 
dence of the pressure variation that occurs during each heart 
beat. Hereby, it is possible to provide an efficient control of 
the inflation in order to obtain both adequate closure of the 
aneurysm and sufficient blood flow through the stent device. 
Notably, both the above-discussed balloon and the above 
discussed Supporting stent are useable separately. 
For example, the balloon may function without the spiral 
stent since the balloon itselfhas a channel and the balloon will 
cover the rupture. The advantage with a spiral-stent present is 
that the flow of blood to the legs is more secure through the 
central part of the balloon. Furthermore, the lower opening of 
the balloon will be better positioned in relation to the iliac 
arteries to the legs and the shape of the upper Surface of the 
balloon supported. However, the balloon may be used as a 
stent device without any Supporting stent. For example, a 
torus shaped balloon can fill a cavity but still have an open 
channel, which can be further supported by a locally less 
elastic material. This would put an artificial wall against the 
leaking aneurysm. The advantage for Sucha device would e.g. 
be a thinner introducer sheath. 
Further, the Supporting stent discussed above, and in par 
ticular the spiral-stent embodiment, provides a spiral shaped 
tubular vessel that has the properties that it has permeable 
walls and that its cross-sectional area can be altered given the 
tension in the filaments or threads defines its diameter. The 
realizations of such a tube include two or several spirals 
curled interfoliated in different direction. The possibility to 
remove the described spiral-stent is highly advantageous, 
since prior known stents will all remain in place permanently. 
This characteristic is of value in conditions where only a 
temporary dilatation or outwards pressure is needed. An 
example is aortic dissection. In this disease the aortic wall is 
split longitudinally giving rise to a double-barrel conduit. The 
aim of the treatment is to close the false pipe. It can be 
achieved by pressing the membrane separating the false and 
true lumen towards the aortic wall. The stent has to be placed 
in the true lumen. In many occasions the membrane is present 
in connection to crucial arteries (celiac trunk, Superior mesen 
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teric artery, renal arteries, arteries to the spinal cord). With 
today's available therapy clinicians hesitate to apply stents, 
which will be present indefinitely in such areas. It is known 
that the separating membrane will adhere to the aortic wall 
again after a period of healing, in case that these tissues get in 
touch. A solution to the problem would be to apply the above 
discussed spiral-stent until Such a healing has occurred and 
then remove it again. An anti-force can be applied if such an 
alternative stent has its threads forming the spirals extended 
into standard straight configurations at both ends. The threads 
at one end can thereby be snared and the threads at the other 
end pulled. 
A number of variations of the stent device and the kit are 
feasible. This description is only one example to give insights 
to principles of delivery, function and removal of the stent 
device. For example, it is possible to use permeable Support 
ing stents formed of net-like walls or the like, or walls pro 
vided with a plurality of perforations to provide adequate 
permeability. Further, the balloon may, in the insertion dis 
position, be arranged in other ways than in line with the 
Supporting stent, such as within the Supporting stent, or out 
side the Supporting stent. Such and other obvious modifica 
tions must be considered to be within the scope of the present 
invention, as it is defined by the appended claims. It should be 
noted that the above-mentioned embodiments illustrate rather 
than limit the invention, and that those skilled in theart will be 
able to design many alternative embodiments without depart 
ing from the scope of the appended claims. In the claims, any 
reference signs placed between parentheses shall not be con 
Strued as limiting to the claim. The word “comprising does 
not exclude the presence of other elements or steps than those 
listed in the claim. The word “a” or “an' preceding an element 
does not exclude the presence of a plurality of Such elements. 
The invention claimed is: 
1. A stent device for treating an aneurysm comprising: 
an expandable balloon with a channel extending through 
said expandable balloon from one side to another, and 
a Supporting stent connected to said expandable balloon, 
wherein the Supporting stentis, in an operative disposition, 
arranged at least partly within said channel of said 
expandable balloon when said expandable balloon is 
expanded, 
wherein said Supporting stent has walls which are perme 
able to blood, 
wherein the expandable balloon is connected to the Sup 
porting stent only at or adjacent to a proximal end of said 
Supporting stent, and 
wherein the expandable balloon, in an insertion disposi 
tion, is arranged within the Supporting stent, and the 
expandable balloon is eversible into an expanded state 
outside said Supporting stent in the operative disposi 
tion. 
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2. The stent device of claim 1, wherein a relative position 
between the expandable balloon and the Supporting stent in an 
axial direction of the stent device is variable, and 
wherein in the insertion disposition, the expandable bal 
loon and the Supporting stent are arranged in line with 
each other. 
3. The stent device of claim 1, wherein the channel of the 
expandable balloon is arranged in a center of the expandable 
balloon when the expandable balloon has a torus shape in the 
expanded State. 
4. The stent device of claim 1, wherein the supporting stent 
has a variable diameter, said diameter being remotely con 
trollable. 
5. The stent device of claim 1, wherein the supporting stent 
is self-expandable, and automatically strives to resume an 
expanded State after being released from a compressed state. 
6. The stent device of claim 1, wherein the supporting stent 
is formed of threads arranged in at least two interfoliated 
spirals. 
7. The stent device of claim 6, wherein ends of the threads 
forming the at least two interfoliated spirals extend beyond 
the Supporting stent, whereby a diameter of the Supporting 
stent is remotely controllable by varying tension of the 
extending ends of the threads. 
8. The stent device of claim 1, wherein a diameter of the 
Supporting stent in the operative disposition is less than 2 cm. 
9. A kit for treating an aneurysm, comprising: 
a delivery sheath; and 
a stent device according to claim 1, wherein the delivery 
sheath releasably accommodates the stent device. 
10. The kit of claim 9, wherein the expandable balloon, in 
the insertion disposition, is connected to the Supporting stent 
at one end and to the delivery sheath at an opposite end. 
11. The kit of claim 10, wherein the connection between 
the expandable balloon and the delivery sheath is releasable. 
12. The kit of claim 9, wherein at least one of the stent 
device and the delivery sheath comprises markers visible by 
external observation. 
13. The kit of claim 9, further comprising an extraction 
sheath for removal of the stent device from the aneurysm. 
14. The kit of claim 12, wherein the markers are visible, by 
fluoroscopic vision. 
15. A method for treating an aneurysm, comprising: 
inserting the kit according to claim 9 into the aneurysm; 
pulling back the delivery sheath, thereby releasing the stent 
device; and 
expanding the expandable balloon in the aneurysm, 
wherein a fluid communication through the aneurysm is 
created through the channel in the expandable balloon. 
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